These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25168689)

  • 1. Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology--a prospective comparative study.
    Schnack TH; Sørensen RD; Nedergaard L; Høgdall C
    Gynecol Oncol; 2014 Nov; 135(2):278-84. PubMed ID: 25168689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas.
    Usach I; Blansit K; Chen LM; Ueda S; Brooks R; Kapp DS; Chan JK
    Am J Obstet Gynecol; 2015 Feb; 212(2):188.e1-6. PubMed ID: 25149685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis.
    Jordan SJ; Green AC; Whiteman DC; Moore SP; Bain CJ; Gertig DM; Webb PM; ;
    Int J Cancer; 2008 Apr; 122(7):1598-603. PubMed ID: 18058817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serous ovarian, fallopian tube and primary peritoneal cancers: a common disease or separate entities - a systematic review.
    Sørensen RD; Schnack TH; Karlsen MA; Høgdall CK
    Gynecol Oncol; 2015 Mar; 136(3):571-81. PubMed ID: 25615934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
    Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
    Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
    Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographic Clinical and Prognostic Factors of Primary Ovarian Adenocarcinomas of Serous and Clear Cell Histology-A Comparative Study.
    Schnack TH; Høgdall E; Nedergaard L; Høgdall C
    Int J Gynecol Cancer; 2016 Jan; 26(1):82-90. PubMed ID: 26569060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960-2014: A population-based cohort study.
    Leandersson P; Hogberg T; Dickman PW; Malander S; Borgfeldt C
    BMC Cancer; 2021 Apr; 21(1):465. PubMed ID: 33902507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
    Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US.
    Liao CI; Chow S; Chen LM; Kapp DS; Mann A; Chan JK
    Gynecol Oncol; 2018 May; 149(2):318-323. PubMed ID: 29514737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data.
    Barclay M; Gildea C; Poole J; Hirschowitz L; Menon U; Nordin A
    Int J Gynecol Cancer; 2016 Jan; 26(1):56-65. PubMed ID: 26509852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited mutations in fallopian tube, ovarian and primary peritoneal carcinoma: Changes in diagnoses and mutational frequency over 20 years.
    Weiss AS; Swisher E; Pennington KP; Radke M; Khasnavis N; Garcia RL; Kilgore MR; Lee MK; Norquist BM
    Gynecol Oncol; 2020 Oct; 159(1):214-220. PubMed ID: 32709535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: the impact of novel agents.
    Bamias A; Bamia C; Zagouri F; Kostouros E; Kakoyianni K; Rodolakis A; Vlahos G; Haidopoulos D; Thomakos N; Antsaklis A; Dimopoulos MA
    Oncology; 2013; 84(3):158-65. PubMed ID: 23296063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer.
    Tanner EJ; Long KC; Feffer JB; Leitao MM; Abu-Rustum NR; Barakat RR; Chi DS; Gardner GJ
    Gynecol Oncol; 2013 Jan; 128(1):28-33. PubMed ID: 23017819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between primary peritoneal and epithelial ovarian carcinoma: a population-based study.
    Barda G; Menczer J; Chetrit A; Lubin F; Beck D; Piura B; Glezerman M; Modan B; Sadetzki S;
    Am J Obstet Gynecol; 2004 Apr; 190(4):1039-45. PubMed ID: 15118638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer.
    Black D; Iasonos A; Ahmed H; Chi DS; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2007 Oct; 107(1):66-70. PubMed ID: 17614125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomes.
    Rottmann M; Burges A; Mahner S; Anthuber C; Beck T; Grab D; Schnelzer A; Kiechle M; Mayr D; Pölcher M; Schubert-Fritschle G; Engel J
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1833-1844. PubMed ID: 28447160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic, Clinical, and Prognostic Factors of Ovarian Clear Cell Adenocarcinomas According to Endometriosis Status.
    Schnack TH; Høgdall E; Thomsen LN; Høgdall C
    Int J Gynecol Cancer; 2017 Nov; 27(9):1804-1812. PubMed ID: 28976447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of retroperitoneal dissemination of primary peritoneum cancer: basis for rational use of lymphadenectomy.
    Aletti GD; Powless C; Bakkum-Gamez J; Wilson TO; Podratz KC; Cliby WA
    Gynecol Oncol; 2009 Jul; 114(1):32-6. PubMed ID: 19361840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.